Kappa opioids inhibit spinal output neurons to suppress itch.
Science advances • Vol. 10, Issue 39 • 2024
Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist.
Handbook of experimental pharmacology • Vol. 271 • 2022
Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
The Journal of pharmacology and experimental therapeutics • Vol. 312, Issue 1 • 2005
Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
European journal of pharmacology • Vol. 376, Issue 1-2 • 1999
